Ratings by RBC Capital (Kennen MacKay)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/16/2024 | Exelixis | EXEL | Maintain | Outperform (N/A) |
|
Details | ||
| 9/30/2024 | Prothena Corp | PRTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/15/2024 | Viracta Therapeutics | VIRX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/9/2024 | Prothena Corp | PRTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/2/2024 | Agios Pharma | AGIO | Maintain | Outperform (N/A) |
|
Details | ||
| 6/26/2024 | Prothena Corp | PRTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 6/3/2024 | Agios Pharma | AGIO | Maintain | Outperform (N/A) |
|
Details | ||
| 5/9/2024 | Prothena Corp | PRTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/3/2024 | Agios Pharma | AGIO | Maintain | Outperform (N/A) |
|
Details | ||
| 5/1/2024 | Exelixis | EXEL | Maintain | Outperform (N/A) |
|
Details | ||
| 4/17/2024 | Nuvation Bio Inc | NUVB | Maintain | Outperform (N/A) |
|
Details | ||
| 2/15/2024 | Agios Pharma | AGIO | Maintain | Outperform (N/A) |
|
Details | ||
| 2/7/2024 | Exelixis | EXEL | Maintain | Outperform (N/A) |
|
Details | ||
| 1/25/2024 | Prothena Corp | PRTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/10/2023 | Viracta Therapeutics | VIRX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2023 | Nuvation Bio Inc | NUVB | Maintain | Outperform (N/A) |
|
Details | ||
| 11/2/2023 | Prothena Corp | PRTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/1/2023 | Amgen | AMGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/4/2023 | Amgen | AMGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 6/27/2023 | Agios Pharma | AGIO | Maintain | Outperform (N/A) |
|
Details | ||
| 6/9/2023 | Regeneron Pharma | REGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/9/2023 | Viracta Therapeutics | VIRX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/5/2023 | Regeneron Pharma | REGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/5/2023 | Prothena Corp | PRTA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/5/2023 | Nuvation Bio Inc | NUVB | Maintain | Outperform (N/A) |
|
Details | ||
| 3/20/2023 | Regeneron Pharma | REGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/9/2023 | Regeneron Pharma | REGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/6/2023 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/8/2023 | Exelixis | EXEL | Maintain | Outperform (N/A) |
|
Details | ||
| 2/6/2023 | Regeneron Pharma | REGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/11/2022 | Viracta Therapeutics | VIRX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/4/2022 | Regeneron Pharma | REGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/4/2022 | Amgen | AMGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/4/2022 | Agios Pharma | AGIO | Maintain | Outperform (N/A) |
|
Details | ||
| 11/4/2022 | Prothena Corp | PRTA | Downgrade | Sector Perform (Outperform) |
57.69 (9.29) |
-83.9% | Details | |
| 11/2/2022 | Exelixis | EXEL | Maintain | Outperform (N/A) |
|
Details | ||
| 10/28/2022 | Seagen | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/13/2022 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 9/28/2022 | Prothena Corp | PRTA | Maintain | Outperform (N/A) |
|
Details | ||
| 9/8/2022 | Regeneron Pharma | REGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/16/2022 | Seagen | SGEN | Upgrade | Outperform (Sector Perform) |
170.14 (228.74) |
34.44% | Details | |
| 8/5/2022 | Nuvation Bio Inc | NUVB | Maintain | Outperform (N/A) |
|
Details | ||
| 8/5/2022 | Amgen | AMGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/5/2022 | Agios Pharma | AGIO | Maintain | Outperform (N/A) |
|
Details | ||
| 8/4/2022 | Regeneron Pharma | REGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 6/23/2022 | Regeneron Pharma | REGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/11/2022 | Nuvation Bio Inc | NUVB | Maintain | Outperform (N/A) |
|
Details | ||
| 5/5/2022 | Agios Pharma | AGIO | Maintain | Outperform (N/A) |
|
Details | ||
| 5/5/2022 | Regeneron Pharma | REGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/2/2022 | Prothena Corp | PRTA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/2/2022 | Regeneron Pharma | REGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/29/2022 | Seagen | SGEN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/28/2022 | Amgen | AMGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/21/2022 | Immunogen Inc. | IMGN | Downgrade | Sector Perform (Outperform) |
5.26 (31.25) |
494.11% | Details | |
| 3/17/2022 | Athenex | ATNX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/25/2022 | Agios Pharma | AGIO | Maintain | Outperform (N/A) |
|
Details | ||
| 2/17/2022 | Genmab A/S | GMAB | Maintain | Outperform (N/A) |
|
Details | ||
| 2/1/2022 | Viracta Therapeutics | VIRX | New Coverage | Outperform (N/A) |
2.41 (0.08) |
-96.68% | Details | |
| 1/11/2022 | Regeneron Pharma | REGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 1/11/2022 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 12/21/2021 | Amgen | AMGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 12/14/2021 | Arena Pharma | ARNA | Downgrade | Sector Perform (Outperform) |
49.94 (99.98) |
100.2% | Details | |
| 11/22/2021 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/3/2021 | Exelixis | EXEL | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2021 | Amgen | AMGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/11/2021 | Athenex | ATNX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/5/2021 | Amgen | AMGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 9/30/2021 | Prothena Corp | PRTA | Maintain | Outperform (N/A) |
|
Details | ||
| 9/27/2021 | Seagen | SGEN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 9/27/2021 | Genmab A/S | GMAB | Maintain | Outperform (N/A) |
|
Details | ||
| 9/27/2021 | Acceleron Pharma | XLRN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 9/7/2021 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/12/2021 | Genmab A/S | GMAB | Maintain | Outperform (N/A) |
|
Details | ||
| 8/6/2021 | Puma Biotechnology | PBYI | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/6/2021 | Athenex | ATNX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/29/2021 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 7/23/2021 | Acceleron Pharma | XLRN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 7/23/2021 | Regeneron Pharma | REGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 7/19/2021 | Prothena Corp | PRTA | Maintain | Outperform (N/A) |
|
Details | ||
| 6/10/2021 | Prothena Corp | PRTA | Maintain | Outperform (N/A) |
|
Details | ||
| 6/7/2021 | Amgen | AMGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/30/2021 | Seagen | SGEN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/30/2021 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/30/2021 | Agios Pharma | AGIO | Maintain | Outperform (N/A) |
|
Details | ||
| 4/30/2021 | Nurix | NRIX | New Coverage | Outperform (N/A) |
34.74 (27.79) |
-20.01% | Details | |
| 4/28/2021 | Amgen | AMGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/6/2021 | Nuvation Bio Inc | NUVB | New Coverage | Outperform (N/A) |
10.85 (7.26) |
-33.09% | Details | |
| 3/2/2021 | Athenex | ATNX | Maintain | Outperform (Outperform) |
|
Details | ||
| 2/26/2021 | Prothena Corp | PRTA | Upgrade | Outperform (Sector Perform) |
22.95 (57.69) |
151.37% | Details | |
| 2/16/2021 | Seagen | SGEN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/1/2021 | Seagen | SGEN | Downgrade | Sector Perform (Outperform) |
164.27 (228.74) |
39.25% | Details | |
| 1/4/2021 | Genmab A/S | GMAB | Maintain | Outperform (N/A) |
|
Details | ||
| 12/30/2020 | Regeneron Pharma | REGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 12/14/2020 | Alexion Pharmaceuticals | ALXN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2020 | Arena Pharma | ARNA | Maintain | Outperform (N/A) |
|
Details | ||
| 10/30/2020 | Seagen | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2020 | Amgen | AMGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/7/2020 | Alexion Pharmaceuticals | ALXN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/14/2020 | Seattle Genetics | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/4/2020 | Akebia Therapeutics | AKBA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/19/2020 | BioMarin Pharmaceutical Inc. | BMRN | Downgrade | Sector Perform (Outperform) |
118.54 (69.33) |
-41.51% | Details | |
| 8/13/2020 | Genmab A/S | GMAB | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2020 | Clovis Oncology | CLVS | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2020 | Acceleron Pharma | XLRN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/5/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 7/31/2020 | Seattle Genetics | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 7/31/2020 | Aimmune Therapeutics | AIMT | Maintain | Outperform (N/A) |
|
Details | ||
| 7/31/2020 | Agios Pharma | AGIO | Maintain | Outperform (N/A) |
|
Details | ||
| 6/25/2020 | Acceleron Pharma | XLRN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 6/19/2020 | Genmab A/S | GMAB | Maintain | Outperform (N/A) |
|
Details | ||
| 5/26/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/12/2020 | Aimmune Therapeutics | AIMT | Maintain | Outperform (N/A) |
|
Details | ||
| 5/8/2020 | Abeona Therapeutics | ABEO | Maintain | Outperform (N/A) |
|
Details | ||
| 5/6/2020 | Regeneron Pharma | REGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/6/2020 | Akebia Therapeutics | AKBA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/5/2020 | Akebia Therapeutics | AKBA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/1/2020 | Seattle Genetics | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/1/2020 | Agios Pharma | AGIO | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/20/2020 | Seattle Genetics | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/18/2020 | Abeona Therapeutics | ABEO | Maintain | Outperform (N/A) |
|
Details | ||
| 2/27/2020 | Arena Pharma | ARNA | Maintain | Outperform (N/A) |
|
Details | ||
| 2/18/2020 | Immunogen Inc. | IMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/7/2020 | Seattle Genetics | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/5/2020 | Seattle Genetics | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/31/2020 | Alexion Pharmaceuticals | ALXn | New Coverage | Outperform (N/A) |
100.30 (182.01) |
81.47% | Details | |
| 1/31/2020 | Alexion Pharmaceuticals | ALXN | New Coverage | Outperform (N/A) |
100.30 (100.30) |
0% | Details | |
| 1/28/2020 | Acceleron Pharma | XLRN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 1/24/2020 | Amgen | AMGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 1/24/2020 | BioMarin Pharmaceutical Inc. | BMRN | Upgrade | Outperform (Sector Perform) |
85.63 (118.54) |
38.43% | Details | |
| 12/16/2019 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 12/10/2019 | ObsEva | OBSV | Maintain | Outperform (N/A) |
|
Details | ||
| 11/19/2019 | Athenex | ATNX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2019 | ObsEva | OBSV | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2019 | Puma Biotechnology | PBYI | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/7/2019 | Acceleron Pharma | XLRN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/1/2019 | Agios Pharma | AGIO | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2019 | Exelixis | EXEL | Maintain | Outperform (N/A) |
|
Details | ||
| 10/30/2019 | Seattle Genetics | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/22/2019 | Seattle Genetics | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/11/2019 | Ra Pharma | RARX | Downgrade | Sector Perform (Outperform) |
22.69 (48.00) |
111.55% | Details | |
| 10/1/2019 | Agios Pharma | AGIO | Maintain | Outperform (N/A) |
|
Details | ||
| 9/30/2019 | Amgen | AMGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 9/18/2019 | Alexion Pharmaceuticals | ALXN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/12/2019 | Aimmune Therapeutics | AIMT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/27/2019 | Amgen | AMGn | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/21/2019 | Amgen | AMGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/21/2019 | Amgen | AMGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/13/2019 | Abeona Therapeutics | ABEO | Maintain | Outperform (N/A) |
|
Details | ||
| 8/9/2019 | Puma Biotechnology | PBYI | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/9/2019 | Akebia Therapeutics | AKBA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/9/2019 | Aimmune Therapeutics | AIMT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2019 | ObsEva | OBSV | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2019 | Regeneron Pharma | REGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/6/2019 | Acceleron Pharma | XLRN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/5/2019 | Immunogen Inc. | IMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/2/2019 | Clovis Oncology | CLVS | Maintain | Outperform (N/A) |
|
Details | ||
| 8/2/2019 | Agios Pharma | AGIO | Maintain | Outperform (N/A) |
|
Details | ||
| 8/1/2019 | Exelixis | EXEL | Maintain | Outperform (N/A) |
|
Details | ||
| 7/31/2019 | Amgen | AMGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 7/17/2019 | Seattle Genetics | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 7/2/2019 | Ra Pharma | RARX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/28/2019 | Immunogen Inc. | IMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 6/25/2019 | Athenex | ATNX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/16/2019 | Agios Pharma | AGIO | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2019 | Puma Biotechnology | PBYI | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/10/2019 | Akebia Therapeutics | AKBA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/8/2019 | Regeneron Pharma | REGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/8/2019 | Clovis Oncology | CLVS | Maintain | Outperform (N/A) |
|
Details | ||
| 5/2/2019 | Exelixis | EXEL | Maintain | Outperform (N/A) |
|
Details | ||
| 4/26/2019 | Seattle Genetics | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/5/2019 | Amgen | AMGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/5/2019 | Seattle Genetics | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/2/2019 | Puma Biotechnology | PBYI | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/29/2019 | Seattle Genetics | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/27/2019 | Alexion Pharmaceuticals | ALXN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/26/2019 | Aimmune Therapeutics | AIMT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/20/2019 | Abeona Therapeutics | ABEO | Maintain | Outperform (N/A) |
|
Details | ||
| 3/12/2019 | Seattle Genetics | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/12/2019 | Athenex | ATNX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/6/2019 | ObsEva | OBSV | Maintain | Outperform (N/A) |
|
Details | ||
| 3/4/2019 | Immunogen Inc. | IMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2019 | Puma Biotechnology | PBYI | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/27/2019 | Clovis Oncology | CLVS | Maintain | Outperform (N/A) |
|
Details | ||
| 2/27/2019 | Arena Pharma | ARNA | Maintain | Outperform (N/A) |
|
Details | ||
| 2/13/2019 | Exelixis | EXEL | Maintain | Outperform (N/A) |
|
Details | ||
| 2/5/2019 | Alexion Pharmaceuticals | ALXN | Maintain | Outperform (N/A) |
|
Details | ||
| 12/20/2018 | Aimmune Therapeutics | AIMT | Maintain | Outperform (N/A) |
|
Details | ||
| 12/18/2018 | Puma Biotechnology | PBYI | Maintain | Sector Perform (N/A) |
|
Details | ||
| 12/6/2018 | Puma Biotechnology | PBYI | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/16/2018 | Alexion Pharmaceuticals | ALXN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/16/2018 | Arena Pharma | ARNA | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2018 | Clovis Oncology | CLVS | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2018 | Clovis Oncology | CLVS | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2018 | Amgen | AMGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/26/2018 | Seattle Genetics | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/26/2018 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/19/2018 | Clovis Oncology | CLVS | Maintain | Outperform (N/A) |
|
Details | ||
| 10/1/2018 | Seattle Genetics | SGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/25/2018 | Alexion Pharmaceuticals | ALXN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/5/2018 | Tesaro | TSRO | Maintain | Sector Perform (N/A) |
|
Details |
